Clinical Trials
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0515
Phase II Trial of Standard Dose Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) and Rituximab Plus Bevacizumab for Advanced Stage Diffuse Large B-Cell NHL
Research Committee(s)
Lymphoma
Activated
06-15-2005
Closed
09-15-2008
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0508
Phase II Trial of Combination Thalidomide plus Temozolomide in Patients with Metastatic Melanoma
Research Committee(s)
Melanoma
Activated
06-01-2005
Closed
01-01-2007
Closed
Phase
Accrual
29%
Published
SWOG Clinical Trial Number
S0414
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial with Molecular Correlates
Research Committee(s)
Gastrointestinal Cancer
Activated
05-01-2005
Closed
09-01-2007
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
S0333
Closed
Phase
Accrual
2%
SWOG Clinical Trial Number
S0340
A Prospective Observational Study of Patients with Solitary Plasmacytoma Using a Modified Staging System Supplemented by an MRI and Whole Body FDG-PET Scan
Research Committee(s)
Myeloma
Activated
04-15-2005
Closed
02-15-2007
Closed
Phase
Accrual
62%
Published
SWOG Clinical Trial Number
S0418
A Phase II Study of SB-715992 (NSC-727990, IND-70273) in Taxane-Resistant Androgen-Independent Metastatic Prostate Cancer
Research Committee(s)
Genitourinary Cancer
Activated
04-01-2005
Closed
05-01-2006
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0329
Phase II Study of Biweekly Gemcitabine and Paclitaxel (GEMTAX) Combination in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Research Committee(s)
Head and Neck Cancer
Activated
01-01-2005
Closed
01-01-2007
Closed
Phase
Accrual
0%
SWOG Clinical Trial Number
S0347
A Randomized Study of Weekly Vinorelbine (Navelbine®) Alone or in Combination With Trastuzumab (Herceptin®) (NSC-688097) for Patients With Her-2 Positive Metastatic Breast Cancer Whose Tumors Have Progressed After Taxane + Trastuzumab Combination Therapy – Phase III
Research Committee(s)
Breast Cancer
Activated
12-15-2004
Closed
02-01-2006
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0413
Phase II Study of GW572016 (NSC #727989) as First Line Therapy in Patients with Advanced or Metastatic Gastric Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
12-15-2004
Closed
05-15-2006
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0312
A Phase II Study of IV Gemcitabine and Oral Capecitabine in Patients with Advanced Renal Cell Cancer
Research Committee(s)
Genitourinary Cancer
Activated
12-01-2004
Closed
08-15-2005
Closed
Phase
Accrual
33%
SWOG Clinical Trial Number
S0344
A Phase II Surgical Trial of Intralesional Resection of Low-Grade Intracompartmental Chondrosarcoma of Bone
Research Committee(s)
Sarcoma
Activated
12-01-2004
Closed
01-15-2007
Closed
Phase
Accrual
40%
Published
SWOG Clinical Trial Number
S0232
Double-Blinded Placebo Controlled Phase III Trial Comparing Dexamethasone (DEX) to the Combination of DEX + CC-5013 in Patients with Previously Untreated Multiple Myeloma who are Not Immediately Undergoing Autologous Stem Cell Transplant
Research Committee(s)
Myeloma
Activated
11-01-2004
Closed
05-11-2007
Closed
Phase
Accrual
8%
SWOG Clinical Trial Number
S0300
Randomized Placebo-Controlled Biomarker Modulation Trial Using Celecoxib in Premenopausal Women at High Risk for Breast Cancer
Research Committee(s)
Breast Cancer
Activated
11-01-2004
Closed
05-13-2008
Closed
Phase
Accrual
5%
SWOG Clinical Trial Number
S0224
Phase II Study of Weekly Docetaxel in Patients with Advanced Epidermoid Carcinoma of the Penis
Research Committee(s)
Genitourinary Cancer
Activated
10-15-2004
Closed
11-15-2005
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0415
Cetuximab as a Second Line Therapy in Patients with Metastatic Esophageal Cancer - Phase II
Activated
10-15-2004
Closed
01-01-2007
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0420
Phase II Evaluation of BAY 43-9006 (NSC-724772) in Patients with Recurrent or Metastatic Head and Neck Cancer
Research Committee(s)
Head and Neck Cancer
Activated
10-01-2004
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0341
Phase II Trial of OSI-774 (NSC-718781) in Patients with Advanced Non-Small Cell Lung Cancer and a Performance Status of 2
Research Committee(s)
Lung Cancer
Activated
09-15-2004
Closed
10-01-2005
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0356
Oxaliplatin Plus Protracted Infusion 5-Fluorouracil and Radiation for Potentially Curable Esophageal Cancer: A Phase II Trial with Molecular Correlates
Research Committee(s)
Gastrointestinal Cancer
Activated
09-15-2004
Closed
08-01-2008
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0432
Phase II Studies of Two Different Schedules and Two Different Doses of the Farnesyl Transferase Inhibitor R115777 (Tipifarnib, Zarnestra�, NSC-702818)for Previously Untreated Acute Myeloid Leukemia (AML) in Patients of Age 70 or Older.
Research Committee(s)
Leukemia
Activated
09-15-2004
Closed
02-21-2006
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0412
A Phase II Study of the RAF-Kinase Inhibitor BAY 43-9006 (NSC-724772, IND-69,896) in Combination with Interferon Alpha 2b in Patients wtih Advanced Renal Cancer
Research Committee(s)
Genitourinary Cancer
Activated
09-01-2004
Closed
05-15-2005